Conversely, prolonged survival was observed in a subgroup of patients with upper thoracic ESCC, grade 3 injection-site reactions, and a high immune response, with ≥ 100 peptide-specific spots for CDCA1 and MPHOSPH1. The gene discussed is KIF20B; the disease is esophageal squamous cell carcinoma.